MedAvante Services

MedAvante's mission is to help improve the efficiency of CNS drug development and reduce development program risk by enhancing the quality of the clinical investigations used to evaluate drugs.  We do this by using methods to make symptom measurements inherently less variable and more consistently reliable. To accomplish this goal, MedAvante offers a range of risk reduction services:

•    MedAvante Central Ratings
•    MedAvante Central Scoring
•    MedAvante Continuous Quality Control (CQC)
•    MedAvante Rater Training

Sponsors of CNS clinical trials can select the precise mix of services needed to achieve their goals for signal detection, study power, and interrater reliability.